Related Experiment Video
Updated: May 18, 2026

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
The role of annexin A3 playing in cancers
Na Wu1, Shuqing Liu, Chunmei Guo
1Department of Biotechnology, Dalian Medical University, Dalian, 116044, China.
Abstract:
Annexin family proteins are a well-known multigene family of Ca(2+)-regulated phospholipid- and membrane-binding proteins. As one of the annexin family genes/proteins, accumulated researches have begun to reveal that annexin A3 (Anxa3) exhibits important roles in tumor development, metastasis and drug resistance. The summarized research evidences in recent years indicate Anxa3 might specifically functionalize either as a tumor suppressor or as a tumor promoter candidate for different cancers depending on the types of tumor cells and tissues. The up-regulation of Anxa3 was found to be correlated with enhanced drug resistance of ovarian cancer, to promote the developments of colorectal adenocarcinoma and pancreatic carcinoma, and to facilitate the metastases of lung adenocarcinoma and hepatocarcinoma; meanwhile, the decreased Anxa3 expressions was negatively correlated with the developments of prostatic carcinoma and renal carcinoma. It is conceivable that Anxa3 could be regarded as a target for therapeutic intervention and a biological indicator for tumor development, invasion and metastasis as well as for the prognosis of tumor patients.
Insights
Annexin A3 (Anxa3) plays a dual role in cancer, acting as a tumor suppressor or promoter. Its expression levels correlate with tumor development, metastasis, and drug resistance across various cancers.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Annexin family proteins are Ca(2+)-regulated phospholipid- and membrane-binding proteins.
- Annexin A3 (Anxa3) is increasingly recognized for its involvement in cancer progression.
- Anxa3's function can vary, acting as either a tumor suppressor or promoter depending on cancer type.
Purpose of the Study:
- To summarize current research on the role of Annexin A3 in cancer.
- To elucidate the dual function of Anxa3 in tumor development, metastasis, and drug resistance.
- To highlight Anxa3 as a potential biomarker and therapeutic target in oncology.
Main Methods:
- Review of accumulated research evidence on Annexin A3.
- Analysis of Anxa3 expression correlations with various cancer types.
- Synthesis of data on Anxa3's impact on tumor progression and drug resistance.
Main Results:
- Anxa3 up-regulation is linked to enhanced drug resistance in ovarian cancer.
- Anxa3 promotes colorectal and pancreatic adenocarcinoma development.
- Anxa3 facilitates lung and hepatocarcinoma metastasis.
- Decreased Anxa3 expression is negatively correlated with prostatic and renal carcinoma development.
Conclusions:
- Annexin A3 exhibits context-dependent roles in cancer, acting as either a suppressor or promoter.
- Anxa3 expression levels serve as potential biomarkers for tumor development, invasion, metastasis, and patient prognosis.
- Anxa3 represents a promising target for novel cancer therapeutic interventions.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Intracellular Signaling Affects Focal Adhesions
Some...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Selectins
The Intrinsic Apoptotic Pathway
Abnormal Proliferation

